Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents

被引：109

作者：

Chackalamannil, S ^{[1
]}

Xia, Y ^{[1
]}

Greenlee, WJ ^{[1
]}

Clasby, M ^{[1
]}

Doller, D ^{[1
]}

Tsai, H ^{[1
]}

Asberom, T ^{[1
]}

Czarniecki, M ^{[1
]}

Ahn, HS ^{[1
]}

Boykow, G ^{[1
]}

Foster, C ^{[1
]}

Agans-Fantuzzi, J ^{[1
]}

Bryant, M ^{[1
]}

Lau, J ^{[1
]}

Chintala, M ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2005年 / 48卷 / 19期

关键词：

D O I：

10.1021/jm0502236

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Structurally novel thrombin receptor (protease activated receptor 1, PAR-1) antagonists based on the natural product himbacine are described. The prototypical PAR-1 antagonist 55 showed a K-i of 2.7 nM in the binding assay, making it the most potent PAR-1 antagonist reported. 55 was highly active in several functional assays, showed excellent oral bioavailability in rat and monkey models, and showed complete inhibition of agonist-induced ex. vivo platelet aggregation in cynomolgus monkeys after oral administration.

引用

页码：5884 / 5887

页数：4

共 32 条

[1] Binding of a thrombin receptor tethered ligand analogue to human platelet thrombin receptor
Ahn, HS
Foster, C
Boykow, G
Arik, L
SmithTorhan, A
Hesk, D
Chatterjee, M
[J]. MOLECULAR PHARMACOLOGY, 1997, 51 (02) : 350 - 356
[2] Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
Ahn, HS
Foster, C
Boykow, G
Stamford, A
Manna, M
Graziano, M
[J]. BIOCHEMICAL PHARMACOLOGY, 2000, 60 (10) : 1425 - 1434
[3] Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor
Andrade-Gordon, P
Mayanoff, BE
Derian, CK
Zhang, HC
Addo, MF
Darrow, AL
Eckardt, AJ
Hoekstra, WJ
McComsey, DF
Oksenberg, D
Reynolds, EE
Santulli, RJ
Scarborough, RM
Smith, CE
White, KB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12257 - 12262
[4] PLATELET-AGGREGATION MONITORED IN A 96-WELL MICROPLATE READER IS USEFUL FOR EVALUATION OF PLATELET AGONISTS AND ANTAGONISTS
BEDNAR, B
CONDRA, C
GOULD, RJ
CONNOLLY, TM
[J]. THROMBOSIS RESEARCH, 1995, 77 (05) : 453 - 463
[5] BISACCHI, 2003, BURGERS MED CHEM DRU, V3, P283
[6] Chackalamannil S, 2001, Curr Opin Drug Discov Devel, V4, P417
[7] A highly efficient total synthesis of (+)-himbacine
Chackalamannil, S
Davies, RJ
Asberom, T
Doller, D
Leone, D
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (40) : 9812 - 9813
[8] Chackalamannil Samuel, 2003, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V1, P37, DOI 10.2174/1568016033356706
[9] The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy
Coller, BS
[J]. EUROPEAN HEART JOURNAL, 1995, 16 : 11 - 15
[10] AN ANTIBODY AGAINST THE EXOSITE OF THE CLONED THROMBIN RECEPTOR INHIBITS EXPERIMENTAL ARTERIAL THROMBOSIS IN THE AFRICAN-GREEN MONKEY
COOK, JJ
SITKO, GR
BEDNAR, B
CONDRA, C
MELLOTT, MJ
FENG, DM
NUTT, RF
SHAFER, JA
GOULD, RJ
CONNOLLY, TM
[J]. CIRCULATION, 1995, 91 (12) : 2961 - 2971

← 1 2 3 4 →